Noriko Satoh-Asahara Selected Research

Dementia (Dementias)

11/2022	Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of patients with diabetes based on their cognitive status.
1/2022	Study protocol to determine the effects of highly absorbable oral curcumin on the indicators of cognitive functioning: a double-blind randomised controlled trial.
3/2020	Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
4/2019	Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives.
1/2019	Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriko Satoh-Asahara Research Topics

Disease

18	Obesity 11/2023 - 01/2011
12	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 02/2011
10	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2015
9	Weight Loss (Weight Reduction) 10/2023 - 02/2012
8	Inflammation (Inflammations) 01/2023 - 03/2011
6	Neoplasms (Cancer) 01/2024 - 11/2020
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2016
6	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2011
5	Cognitive Dysfunction 02/2024 - 01/2019
5	Dementia (Dementias) 11/2022 - 01/2019
5	Chronic Renal Insufficiency 01/2022 - 02/2011
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 02/2011
5	Weight Gain 10/2018 - 01/2013
5	Atherosclerosis 11/2016 - 07/2010
4	Body Weight (Weight, Body) 01/2023 - 02/2012
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2019
4	Insulin Resistance 01/2020 - 01/2011
3	Tobacco Use Disorder (Nicotine Dependence) 01/2024 - 01/2013
3	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 04/2019
3	Hyperaldosteronism (Conn Syndrome) 04/2022 - 12/2019
3	Abdominal Obesity 01/2018 - 11/2015
2	Osteogenesis Imperfecta (Lobstein Disease) 05/2024 - 08/2023
2	Adrenocortical Adenoma (Disease, Conn's) 01/2024 - 12/2022
2	COVID-19 12/2023 - 01/2020
2	Neuroinflammatory Diseases 06/2023 - 05/2017
2	Hyperglycemia 02/2023 - 10/2016
2	Overweight 02/2023 - 03/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2021 - 07/2017
2	Hypertension (High Blood Pressure) 06/2020 - 01/2020
2	Heart Failure 06/2020 - 01/2015
2	Graves Disease (Basedow Disease) 12/2019 - 01/2018
2	Hypercholesterolemia 12/2016 - 01/2011
2	Atherosclerotic Plaque (Atheroma) 01/2013 - 01/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Adenoma (Adenomas) 01/2024
1	Metabolically Benign Obesity 10/2023
1	Congenital Abnormalities (Deformity) 08/2023
1	Hypopituitarism (Sheehan's Syndrome) 08/2023
1	Metabolic Bone Diseases (Osteopenia) 08/2023
1	Carcinogenesis 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 11/2022
1	Mental Disorders (Mental Disorder) 11/2022
1	Fatigue 11/2022

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2015
9	oxidized low density lipoproteinIBA 01/2019 - 07/2010
8	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2013
5	Cystatin CIBA 10/2023 - 02/2011
5	taxifolinIBA 06/2023 - 01/2019
4	AldosteroneIBA 01/2024 - 12/2019
4	CurcuminIBA 09/2022 - 01/2016
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
4	LDL Lipoproteins (beta Lipoproteins)IBA 11/2020 - 01/2012
4	Triglycerides (Triacylglycerol)IBA 11/2020 - 01/2011
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 02/2012
3	EnzymesIBA 01/2024 - 07/2017
3	LipidsIBA 12/2023 - 01/2011
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2014
3	CholesterolIBA 11/2020 - 01/2011
3	Vascular Endothelial Growth Factor CIBA 01/2020 - 01/2011
3	Lipoproteins (Lipoprotein)IBA 11/2016 - 11/2015
3	Eicosapentaenoic AcidIBA 01/2014 - 12/2012
3	HDL CholesterolIBA 01/2013 - 01/2011
2	Carbon MonoxideIBA 01/2024 - 01/2013
2	Insulin (Novolin)FDA Link 12/2023 - 01/2011
2	Uric Acid (Urate)IBA 11/2023 - 01/2020
2	AdiponectinIBA 10/2023 - 01/2018
2	Cell Surface ReceptorsIBA 01/2022 - 12/2018
2	Metformin (Glucophage)FDA LinkGeneric 06/2020 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2020 - 09/2015
2	Sodium-Glucose Transport ProteinsIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 12/2019 - 03/2011
2	AdipokinesIBA 01/2019 - 01/2018
2	LectinsIBA 01/2018 - 07/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016 - 01/2015
2	CreatinineIBA 01/2015 - 02/2011
2	Interleukin-10 (Interleukin 10)IBA 07/2013 - 12/2012
2	LDL CholesterolIBA 01/2013 - 01/2011
1	romosozumabIBA 05/2024
1	ThioredoxinsIBA 02/2024
1	imegliminIBA 02/2024
1	NLR ProteinsIBA 02/2024
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2024
1	visininIBA 01/2024
1	CateninsIBA 01/2024
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023
1	Hormones (Hormone)IBA 08/2023
1	fibroblast growth factor 21IBA 01/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2022
1	GlucocorticoidsIBA 12/2022
1	SteroidsIBA 12/2022
1	AndrogensIBA 12/2022
1	Yi-Gan SanIBA 11/2022

Therapy/Procedure

11	Therapeutics 10/2023 - 01/2011
5	Glycemic Control 05/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 11/2022 - 11/2020
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2020 - 11/2019
2	Carotid Endarterectomy 10/2016 - 01/2011